Ipatasertib (GDC-0068) Study to Evaluate Formulation Change and Food Effect on Bioavailability in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions

Cancer

Interventions

DRUG

Ipatasertib (capsule)

Orally administered single dose of Ipatasertib formulated as a capsule.

DRUG

Ipatasertib (tablet)

Orally administered single dose of Ipatasertib formulated as a tablet.

Trial Locations (1)

Madison